Safety and efficacy of pregabalin in children 4-16 years old with partial onset seizures
Full IRB Study Title:
A double blind, placebo-controlled parallel-group, multicenter study of the efficacy and safety of pregabalin as adjunctive therapy in children 4-16 years of age with partial onset seizures
IRB Study ID: A0081041
Epilepsy is often controlled by current medications. For some children, however, these medicines do not fully control their seizures. Or, these medicines may cause side effects. In this study we want to find out if a medicine (pregabalin) helps reduce partial onset seizures in children. If your child already takes antiepileptic drugs but still has seizures, we will give pregabalin as an add-on medication. Some children may receive a pill without an active drug (a placebo). We can then determine if adding pregabalin reduced seizures.
Who May Qualify:
Full Study Description and Eligibility
- Pediatric patients (4 - 16 years) with partial onset seizures whose partial onset seizures are not controlled by current medication
- Patients with 3 partial onset seizures in a 28-day period before screening for the study
Who Does NOT Qualify:
- Patients with other seizure types or medical conditions
- Patients under 4 years or over 16 years
